CHRNA5 belongs to the secondary estrogen signaling network exhibiting prognostic significance in breast cancer

buir.contributor.authorShehwana, Huma
buir.contributor.authorKeskus, Ayse Gokce
buir.contributor.authorOzdemir, E. Sila
buir.contributor.authorAcikgöz, Azer Aylin
buir.contributor.authorBiyik-Sit, Rumeysa
buir.contributor.authorGunes, Damla
buir.contributor.authorJahja, Ermira
buir.contributor.authorCingir-Koker, Sahika
buir.contributor.authorOlmezer, Gizem
buir.contributor.authorSucularli, Ceren
buir.contributor.authorKonu, Ozlen
buir.contributor.orcidShehwana, Huma|0000-0002-3665-8846
buir.contributor.orcidKeskus, Ayse Gokce|0000-0002-3934-8587
buir.contributor.orcidOzdemir, E. Sila|0000-0003-0046-0667
buir.contributor.orcidBiyik-Sit, Rumeysa|0000-0001-8702-7350
buir.contributor.orcidCingir-Koker, Sahika|0000-0002-8529-4532
buir.contributor.orcidKonu, Ozlen|0000-0002-6223-5329
dc.citation.epage472en_US
dc.citation.spage453en_US
dc.citation.volumeNumber44en_US
dc.contributor.authorShehwana, Huma
dc.contributor.authorKeskus, Ayse Gokce
dc.contributor.authorOzdemir, E. Sila
dc.contributor.authorAcikgöz, Azer Aylin
dc.contributor.authorBiyik-Sit, Rumeysa
dc.contributor.authorCagnan, I.
dc.contributor.authorGunes, Damla
dc.contributor.authorJahja, Ermira
dc.contributor.authorCingir-Koker, Sahika
dc.contributor.authorOlmezer, Gizem
dc.contributor.authorSucularli, Ceren
dc.contributor.authorKonu, Ozlen
dc.date.accessioned2022-02-16T13:18:47Z
dc.date.available2022-02-16T13:18:47Z
dc.date.issued2021-04
dc.departmentDepartment of Molecular Biology and Geneticsen_US
dc.departmentInstitute of Materials Science and Nanotechnology (UNAM)en_US
dc.departmentInterdisciplinary Program in Neuroscience (NEUROSCIENCE)en_US
dc.description.abstractCholinergic signals can be important modulators of cellular signaling in cancer. We recently have shown that knockdown of nicotinic acetylcholine receptor subunit alpha 5, CHRNA5, diminishes the proliferative potential of breast cancer cells. However, modulation of CHRNA5 expression in the context of estrogen signaling and its prognostic implications in breast cancer remained unexplored.en_US
dc.description.provenanceSubmitted by Dilan Ayverdi (dilan.ayverdi@bilkent.edu.tr) on 2022-02-16T13:18:47Z No. of bitstreams: 1 CHRNA5_belongs_to_the_secondary_estrogen_signaling_network_exhibiting_prognostic_significance_in_breast_cancer.pdf: 6334954 bytes, checksum: c1e786e0611bd90756847ce519046fb6 (MD5)en
dc.description.provenanceMade available in DSpace on 2022-02-16T13:18:47Z (GMT). No. of bitstreams: 1 CHRNA5_belongs_to_the_secondary_estrogen_signaling_network_exhibiting_prognostic_significance_in_breast_cancer.pdf: 6334954 bytes, checksum: c1e786e0611bd90756847ce519046fb6 (MD5) Previous issue date: 2021-04en
dc.identifier.doi10.1007/s13402-020-00581-xen_US
dc.identifier.eissn1875-8606
dc.identifier.urihttp://hdl.handle.net/11693/77429
dc.language.isoEnglishen_US
dc.publisherSpringeren_US
dc.relation.isversionofhttps://doi.org/10.1007/s13402-020-00581-xen_US
dc.source.titleCellular Oncologyen_US
dc.subjectBreast canceren_US
dc.subjectCHRNA5en_US
dc.subjectMeta-analysisen_US
dc.subjectCo-expression networken_US
dc.subjectEstrogen receptor targetsen_US
dc.subjectEstrogen treatmenten_US
dc.subjectPrognosisen_US
dc.titleCHRNA5 belongs to the secondary estrogen signaling network exhibiting prognostic significance in breast canceren_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
CHRNA5_belongs_to_the_secondary_estrogen_signaling_network_exhibiting_prognostic_significance_in_breast_cancer.pdf
Size:
6.04 MB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.69 KB
Format:
Item-specific license agreed upon to submission
Description: